These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 9416499)
1. What can we learn about human immunodeficiency virus infection from a study of lymphocytic choriomeningitis virus? Klenerman P; Zinkernagel RM Immunol Rev; 1997 Oct; 159():5-16. PubMed ID: 9416499 [TBL] [Abstract][Full Text] [Related]
2. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. Ahmed R; Salmi A; Butler LD; Chiller JM; Oldstone MB J Exp Med; 1984 Aug; 160(2):521-40. PubMed ID: 6332167 [TBL] [Abstract][Full Text] [Related]
3. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. VI. Migration and activity in vivo in acute and persistent infection. Byrne JA; Oldstone MB J Immunol; 1986 Jan; 136(2):698-704. PubMed ID: 2416821 [TBL] [Abstract][Full Text] [Related]
4. Infection of lymphocytes by a virus that aborts cytotoxic T lymphocyte activity and establishes persistent infection. Borrow P; Tishon A; Oldstone MB J Exp Med; 1991 Jul; 174(1):203-12. PubMed ID: 1905339 [TBL] [Abstract][Full Text] [Related]
6. Impact of CCR7 on priming and distribution of antiviral effector and memory CTL. Junt T; Scandella E; Förster R; Krebs P; Krautwald S; Lipp M; Hengartner H; Ludewig B J Immunol; 2004 Dec; 173(11):6684-93. PubMed ID: 15557160 [TBL] [Abstract][Full Text] [Related]
7. Lysis of infected cells in vivo by antiviral cytolytic T cells demonstrated by release of cell internal viral proteins. Kyburz D; Speiser DE; Battegay M; Hengartner H; Zinkernagel RM Eur J Immunol; 1993 Jul; 23(7):1540-5. PubMed ID: 8325330 [TBL] [Abstract][Full Text] [Related]
8. A functional and kinetic comparison of antiviral effector and memory cytotoxic T lymphocyte populations in vivo and in vitro. Ehl S; Klenerman P; Aichele P; Hengartner H; Zinkernagel RM Eur J Immunol; 1997 Dec; 27(12):3404-13. PubMed ID: 9464829 [TBL] [Abstract][Full Text] [Related]
9. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response. Nahill SR; Welsh RM J Exp Med; 1993 Feb; 177(2):317-27. PubMed ID: 8093891 [TBL] [Abstract][Full Text] [Related]
10. Low-affinity cytotoxic T-lymphocytes require IFN-gamma to clear an acute viral infection. Von Herrath MG; Coon B; Oldstone MB Virology; 1997 Mar; 229(2):349-59. PubMed ID: 9126248 [TBL] [Abstract][Full Text] [Related]
14. Consequences of cytotoxic T lymphocyte interaction with major histocompatibility complex class I-expressing neurons in vivo. Rall GF; Mucke L; Oldstone MB J Exp Med; 1995 Nov; 182(5):1201-12. PubMed ID: 7595191 [TBL] [Abstract][Full Text] [Related]
15. CD40 ligand is pivotal to efficient control of virus replication in mice infected with lymphocytic choriomeningitis virus. Thomsen AR; Nansen A; Christensen JP; Andreasen SO; Marker O J Immunol; 1998 Nov; 161(9):4583-90. PubMed ID: 9794385 [TBL] [Abstract][Full Text] [Related]
16. Transfer of lymphocytic choriomeningitis disease in beta 2-microglobulin-deficient mice by CD4+ T cells. Quinn DG; Zajac AJ; Frelinger JA; Muller D Int Immunol; 1993 Oct; 5(10):1193-8. PubMed ID: 7903551 [TBL] [Abstract][Full Text] [Related]
17. Pathological changes in the islet milieu precede infiltration of islets and destruction of beta-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM. von Herrath M; Holz A J Autoimmun; 1997 Jun; 10(3):231-8. PubMed ID: 9218748 [TBL] [Abstract][Full Text] [Related]
18. Immunosuppression by lymphocytic choriomeningitis virus infection: competent effector T and B cells but impaired antigen presentation. Althage A; Odermatt B; Moskophidis D; Kündig T; Hoffman-Rohrer U; Hengartner H; Zinkernagel RM Eur J Immunol; 1992 Jul; 22(7):1803-12. PubMed ID: 1623925 [TBL] [Abstract][Full Text] [Related]
19. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes. von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447 [TBL] [Abstract][Full Text] [Related]
20. T cell-mediated hepatitis in mice infected with lymphocytic choriomeningitis virus. Liver cell destruction by H-2 class I-restricted virus-specific cytotoxic T cells as a physiological correlate of the 51Cr-release assay? Zinkernagel RM; Haenseler E; Leist T; Cerny A; Hengartner H; Althage A J Exp Med; 1986 Oct; 164(4):1075-92. PubMed ID: 3489805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]